Hans Vrielink

2.0k citations
68 papers · 902 indexed · h-index 17
Topics
Blood donation and transfusion practices (15 papers)Hepatitis C virus research (14 papers)Hepatitis B Virus Studies (12 papers)

In The Last Decade

Hans Vrielink

63 papers receiving 866 citations

Peers

Hans Vrielink
Comparison fields: 5 of 82
  • Epidemiology 332
  • Hepatology 301
  • Immunology 234
  • Infectious Diseases 165
  • Hematology 138
Replace Shigeharu Uchida with:
Shigeharu Uchida Japan
Charles G. Hollingsworth United States
W. P. Schaasberg Netherlands
Leonor P. Fernando United States
J P Allain United Kingdom
J.‐J. Lefrère France
C. Gazengel France
Deborah Todd United States
Emer Lawlor Ireland
T.J. Cobain Australia
Hans Vrielink relative to Shigeharu Uchida Japan Shigeharu Uchida's profile →
Citations per field
00.5×3.4×
Shigeharu Uchida · 1×
Citations per year

Countries citing papers authored by Hans Vrielink

Since Specialization
Citations

This map shows the geographic impact of Hans Vrielink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Vrielink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Vrielink more than expected).

Fields of papers citing papers by Hans Vrielink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Vrielink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Vrielink. The network helps show where Hans Vrielink may publish in the future.

Co-authorship network of co-authors of Hans Vrielink

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Vrielink. A scholar is included among the top collaborators of Hans Vrielink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Vrielink. Hans Vrielink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 5
5 8
6 3
7 1
8 0
9 7
10 11
11 1
12 1
13 1
14 1
15 37
16 28
17 10
18 38
19 15
20 47

About Hans Vrielink

Hans Vrielink is a scholar working on Management of Technology and Innovation, Hematology and Biochemistry, having authored 68 papers that have together received 902 indexed citations. Recurring topics across this work include Blood donation and transfusion practices (15 papers), Hepatitis C virus research (14 papers) and Hepatitis B Virus Studies (12 papers). The work is most often cited by research in Hepatology (301 citations), Management of Technology and Innovation (95 citations) and Hematology (138 citations). Hans Vrielink has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include H. W. Reesink, Hans L. Zaaijer, P.N. Lelie, C.L. van der Poel, H. T. M. Cuypers, Leendert Porcelijn, Rutger A. Middelburg, H. W. Reesink, Neubury M. Lardy and E Briët. Their work appears in journals such as The Lancet, Journal of Hepatology and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026